2018/03/12 by Sze Lin Yoong, Emily Stockings, Li Kheng Chai +8 · 3 citations
Biochemistry, Genetics and Molecular Biology · Environmental Science · Medicine · #Air Quality and Health Impacts #Demography #Environmental health #Epidemiology #Geography #Grey literature #MEDLINE #Medicine #Meta-analysis #Nicotinic Acetylcholine Receptors Study #Political science #Population #Public health #Smoking Behavior and Cessation #Smoking prevalence
paper · pdf · doi:10.1111/1753-6405.12777
openalex publication_date 2018/03/12 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
OBJECTIVE: To describe the prevalence and change in prevalence of electronic nicotine delivery systems (ENDS) use in youth by country and combustible smoking status. METHODS: Databases and the grey literature were systematically searched to December 2015. Studies describing the prevalence of ENDS use in the general population aged ≤20 years in a defined geographical region were included. Where multiple estimates were available within countries, prevalence estimates of ENDS use were pooled for each country separately. RESULTS: Data from 27 publications (36 surveys) from 13 countries were included. The prevalence of ENDS ever use in 2013-2015 among youth were highest in Poland (62.1%; 95%CI: 59.9-64.2%), and lowest in Italy (5.9%; 95%CI: 3.3-9.2%). Among non-smoking youth, the prevalence of ENDS ever use in 2013-2015 varied, ranging from 4.2% (95%CI: 3.8-4.6%) in the US to 14.0% in New Zealand (95%CI: 12.7-15.4%). The prevalence of ENDS ever use among current tobacco smoking youth was the highest in Canada (71.9%, 95%CI: 70.9-72.8%) and lowest in Italy (29.9%, 95%CI: 18.5-42.5%). Between 2008 and 2015, ENDS ever use among youth increased in Poland, Korea, New Zealand and the US; decreased in Italy and Canada; and remained stable in the UK. CONCLUSIONS: There is considerable heterogeneity in ENDS use among youth globally across countries and also between current smokers and non-smokers. Implications for public health: Population-level survey data on ENDS use is needed to inform public health policy and messaging globally.